Francesco Favero

Francesco Favero

Assistant Professor

Member of:

    ORCID: 0000-0003-3684-2659

    Publication year:
    All
    11 - 20 out of 22Page size: 10
    1. 2017
    2. Published

      Mitochondrial mutations drive prostate cancer aggression

      Hopkins, J. F., Sabelnykova, V. Y., Weischenfeldt, J., Simon, R., Aguiar, J. A., Alkallas, R., Heisler, L. E., Zhang, J., Watson, J. D., Chua, M. L. K., Fraser, M., Favero, F., Lawerenz, C., Plass, C., Sauter, G., McPherson, J. D., Van Der Kwast, T., Korbel, J., Schlomm, T., Bristow, R. G. & 1 others, Boutros, P. C., 1 Dec 2017, In: Nature Communications. 8, 1, 8 p., 656.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer

      López-García, C., Sansregret, L., Domingo, E., McGranahan, N., Hobor, S., Birkbak, N. J., Horswell, S., Grönroos, E., Favero, F., Rowan, A. J., Matthews, N., Begum, S., Phillimore, B., Burrell, R., Oukrif, D., Spencer-Dene, B., Kovac, M., Stamp, G., Stewart, A., Danielsen, H. & 3 others, Novelli, M., Tomlinson, I. & Swanton, C., 9 Jan 2017, In: Cancer Cell. 31, 1, p. 79-93 15 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. 2015

    5. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

      Marquard, A. M., Birkbak, N. J., Thomas, Cecilia Engel, Favero, Francesco, Krzystanek, M., Lefebvre, C., Ferté, C., Jamal-Hanjani, M., Wilson, G. A., Shafi, S., Swanton, C., André, F., Szallasi, Z. & Eklund, A. C., 1 Oct 2015, In: BMC Medical Genomics. 8, p. 58

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome

      Favero, F., McGranahan, N., Salm, M., Birkbak, N. J., Sanborn, J. Z., Benz, S. C., Becq, J., Peden, J. F., Kingsbury, Z., Grocok, R. J., Humphray, S., Bentley, D., Spencer-Dene, B., Gutteridge, A., Brada, M., Roger, S., Dietrich, P-Y., Forshew, T., Gerlinger, M., Rowan, A. & 4 others, Stamp, G., Eklund, A. C., Szallasi, Z. & Swanton, C., May 2015, In: Annals of Oncology. 26, 5, p. 880-7 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

      McGranahan, N., Favero, Francesco, de Bruin, E. C., Birkbak, N. J., Szallasi, Z. & Swanton, C., 15 Apr 2015, In: Science Translational Medicine. 7, 283, p. 283ra54

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data

      Favero, Francesco, Joshi, T., Marquard, A. M., Birkbak, N. J., Krzystanek, M., Li, Q., Szallasi, Z. & Eklund, A. C., Jan 2015, In: Annals of Oncology. 26, 1, p. 64-70 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

      Marquard, A. M., Eklund, A. C., Joshi, T., Krzystanek, M., Favero, Francesco, Wang, Z. C., Richardson, A. L., Silver, D. P., Szallasi, Z. & Birkbak, N. J., 2015, In: Biomarker Research. 3, p. 9

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. 2014

    11. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

      Fisher, R., Horswell, S., Rowan, A., Salm, M. P., de Bruin, E. C., Gulati, S., McGranahan, N., Stares, M., Gerlinger, M., Varela, I., Crockford, A., Favero, F., Quidville, V., André, F., Navas, C., Grönroos, E., Nicol, D., Hazell, S., Hrouda, D., O'Brien, T. & 15 others, Matthews, N., Phillimore, B., Begum, S., Rabinowitz, A., Biggs, J., Bates, P. A., McDonald, N. Q., Stamp, G., Spencer-Dene, B., Hsieh, J. J., Xu, J., Pickering, L., Gore, M., Larkin, J. & Swanton, C., 27 Aug 2014, In: Genome Biology. 15, 8, p. 433

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. 2011

    13. 3-(2,6-dimethylphenyl)-2-selenoxo-1,3-thiazolidin-4-one suppresses hydrogen peroxide-induced cytotoxicity on PC12 cells via activation of MAPK

      Nishina, A., Kimura, H., Kozawa, K., Sommen, G., Favero, Francesco, Heimgartner, H., Koketsu, M. & Furukawa, S., Dec 2011, In: International Journal of Toxicology. 30, 6, p. 690-9 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    14. 2010

    15. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells

      Belgiovine, C., Frapolli, R., Bonezzi, K., Chiodi, I., Favero, Francesco, Mello-Grand, M., Dei Tos, A. P., Giulotto, E., Taraboletti, G., D'Incalci, M. & Mondello, C., 30 Nov 2010, In: PLoS ONE. 5, 11, p. e14154

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1 2 3 Next

    ID: 152300844